Krah D - Search Results

1

Memory T-cell response to rotavirus detected with a gamma interferon enzyme-linked immunospot assay.

Kaufhold RM, Field JA, Caulfield MJ, Wang S, Joseph H, Wooters MA, Green T, Clark HF, Krah D, Smith JG. Kaufhold RM, et al. Among authors: krah d. J Virol. 2005 May;79(9):5684-94. doi: 10.1128/JVI.79.9.5684-5694.2005. J Virol. 2005. PMID: 15827183 Free PMC article.

2

Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants.

Clark HF, Bernstein DI, Dennehy PH, Offit P, Pichichero M, Treanor J, Ward RL, Krah DL, Shaw A, Dallas MJ, Laura D, Eiden JJ, Ivanoff N, Kaplan KM, Heaton P. Clark HF, et al. Among authors: krah dl. J Pediatr. 2004 Feb;144(2):184-90. doi: 10.1016/j.jpeds.2003.10.054. J Pediatr. 2004. PMID: 14760258 Clinical Trial.

3

WC3 reassortant vaccines in children.

Clark HF, Offit PA, Ellis RW, Krah D, Shaw AR, Eiden JJ, Pichichero M, Treanor JJ. Clark HF, et al. Among authors: krah d. Arch Virol Suppl. 1996;12:187-98. doi: 10.1007/978-3-7091-6553-9_20. Arch Virol Suppl. 1996. PMID: 9015115 Review.

4

Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation.

Clark HF, Burke CJ, Volkin DB, Offit P, Ward RL, Bresee JS, Dennehy P, Gooch WM, Malacaman E, Matson D, Walter E, Watson B, Krah DL, Dallas MJ, Schödel F, Kaplan kM, Heaton P. Clark HF, et al. Among authors: krah dl. Pediatr Infect Dis J. 2003 Oct;22(10):914-20. doi: 10.1097/01.inf.0000091887.48999.77. Pediatr Infect Dis J. 2003. PMID: 14551493 Clinical Trial.

5

The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants.

Clark HF, Offit PA, Ellis RW, Eiden JJ, Krah D, Shaw AR, Pichichero M, Treanor JJ, Borian FE, Bell LM, Plotkin SA. Clark HF, et al. Among authors: krah d. J Infect Dis. 1996 Sep;174 Suppl 1:S73-80. doi: 10.1093/infdis/174.supplement_1.s73. J Infect Dis. 1996. PMID: 8752294 Review.

6

Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans.

Sullivan NL, Reuter-Monslow MA, Sei J, Durr E, Davis CW, Chang C, McCausland M, Wieland A, Krah D, Rouphael N, Mehta AK, Mulligan MJ, Pulendran B, Ahmed R, Vora KA. Sullivan NL, et al. Among authors: krah d. J Virol. 2018 Jun 29;92(14):e00269-18. doi: 10.1128/JVI.00269-18. Print 2018 Jul 15. J Virol. 2018. PMID: 29743372 Free PMC article.

7

Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge.

Meyer C, Engelmann F, Arnold N, Krah DL, ter Meulen J, Haberthur K, Dewane J, Messaoudi I. Meyer C, et al. Among authors: krah dl. J Virol. 2015 Feb;89(3):1781-93. doi: 10.1128/JVI.03124-14. Epub 2014 Nov 19. J Virol. 2015. PMID: 25410871 Free PMC article.

8

Further evaluation of a live hepatitis A vaccine in marmosets.

Provost PJ, Banker FS, Wadsworth CW, Krah DL. Provost PJ, et al. Among authors: krah dl. J Med Virol. 1991 Aug;34(4):227-31. doi: 10.1002/jmv.1890340406. J Med Virol. 1991. PMID: 1658214

9

Combined use of complement and anti-immunoglobulin in an enhanced neutralization assay for antibodies to varicella-zoster virus.

Krah DL, Provost PJ, Ellis RW. Krah DL, et al. J Virol Methods. 1995 Jun;53(2-3):176-87. doi: 10.1016/0166-0934(95)00013-k. J Virol Methods. 1995. PMID: 7673386

10

Comparison of gpELISA and neutralizing antibody responses to Oka/Merck live varicella vaccine (Varivax) in children and adults.

Krah DL, Cho I, Schofield T, Ellis RW. Krah DL, et al. Vaccine. 1997 Jan;15(1):61-4. doi: 10.1016/s0264-410x(96)00107-7. Vaccine. 1997. PMID: 9041667

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page